Home LiteratureArticle Details
PMID: 10526099 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.

Brain research ·Vol. 842 ·No. 1 ·1999-09-18 ·Pages 92-100

Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH

Abstract

Blood-brain barrier (BBB) disruption is thought to play a critical role in the pathophysiology of ischemia/reperfusion. Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that can degrade all the components of the extracellular matrix when they are activated. Gelatinase A (MMP-2) and gelatinase B (MMP-9) are able to digest the endothelial basal lamina, which plays a major role in maintaining BBB impermeability. The present study examined the expression and activation of gelatinases before and after transient focal cerebral ischemia (FCI) in mice. Adult male CD1 mice were subjected to 60 min FCI and reperfusion. Zymography was performed from 1 to 23 h after reperfusion using the protein extraction method with detergent extraction and affinity-support purification. MMP-9 expression was also examined by both immunohistochemistry and Western blot analysis, and tissue inhibitors to metalloproteinase-1 was measured by reverse zymography. The BBB opening was evaluated by the Evans blue extravasation method. The 88-kDa activated MMP-9 was absent from the control specimens, while it appeared 3 h after transient ischemia by zymography. At this time point, the BBB permeability alteration was detected in the ischemic brain. Both pro-MMP-9 (96 kDa) and pro-MMP-2 (72 kDa) were seen in the control specimens, and were markedly increased after FCI. A significant induction of MMP-9 was confirmed by both immunohistochemistry and Western blot analysis. The early appearance of activated MMP-9, associated with evidence of BBB permeability alteration, suggests that activation of MMP-9 contributes to the early formation of vasogenic edema after transient FCI.

MeSH Terms
Animals Benzyl Compounds Blood-Brain Barrier/physiology Blotting, Western Collagen/metabolism Collagenases/metabolism Coloring Agents Dexamethasone/pharmacology Drug Combinations Enzyme Inhibitors/pharmacology Evans Blue Gelatinases/antagonists & inhibitors,metabolism Immunohistochemistry Infarction, Middle Cerebral Artery/pathology Ischemic Attack, Transient/enzymology,pathology Male Matrix Metalloproteinase 9/metabolism Matrix Metalloproteinase Inhibitors Mice Pentoxifylline/pharmacology Reperfusion Injury/enzymology,pathology Succinates Tissue Inhibitor of Metalloproteinase-1/biosynthesis
Chemicals
BB 1101 Benzyl Compounds Coloring Agents Drug Combinations Enzyme Inhibitors Matrix Metalloproteinase Inhibitors Succinates Tissue Inhibitor of Metalloproteinase-1 Evans Blue Dexamethasone Collagen Collagenases Gelatinases Matrix Metalloproteinase 9 Pentoxifylline
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Fujimura M
Department of Neurosurgery, Program in Neurosciences, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
Gasche Y
Morita-Fujimura Y
Massengale J
Kawase M
Chan P H
Article Info
Journal
Brain research
Abbr.
Brain Res
ISSN
0006-8993
Published
1999-09-18
Pages
92-100
Language
English
Region
Netherlands
NLM ID
0045503
Subset
IM
Grants
NINDS NIH HHS · NS14543 · United States
NINDS NIH HHS · NS25372 · United States
NINDS NIH HHS · NS36147 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com